Balaji Amines Fires Up Isopropylamine Production, Expands Specialty Chemicals Portfolio

Balaji Amines Ltd has officially commenced commercial production of Isopropylamine (MIPA/DIPA) as of June 30, 2025, marking a significant milestone in its specialty chemicals expansion strategy. The move follows regulatory consent received earlier in June, with trial runs completed successfully at the company’s state-of-the-art facility.

 

Isopropylamine is a key intermediate used in agrochemicals, pharmaceuticals, and rubber processing, and its addition strengthens Balaji’s position in the high-margin amine derivatives segment. The company expects this product to contribute meaningfully to revenue in FY26, especially as global demand for specialty amines continues to rise.

 

The announcement sparked a positive market reaction, with Balaji Amines’ stock climbing over 2% to ₹1,711.90 on the NSE following the regulatory nod. Analysts see the development as a strategic win, aligning with the company’s broader goal of backward integration and import substitution.

 

Balaji Amines has invested heavily in capacity expansion over the past five years, reducing borrowings from ₹260 crore to ₹11 crore and boosting reserves to ₹1,839 crore. The launch of Isopropylamine production is part of a larger capex cycle that includes ramp-ups in DME, DMC, and NBPT capacities.

 

With this launch, Balaji not only diversifies its product mix but also reinforces its leadership in India’s specialty chemicals landscape—positioning itself to tap into both domestic and export markets with greater agility.

 

Sources: Business Upturn, Indian Chemical News, Investing.com